EcoDrugPlus

Fms Related Receptor Tyrosine Kinase 4

Ensembl ID : ENSDNOG00000048259
Gene Symbol: FLT4
2 Cross references
198 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSDNOG00000038875
Gene Symbol: FOLH1
2 Cross references
211 Possible Orthologues:

Folate Receptor Alpha-Like

Ensembl ID : ENSDNOG00000038143
Gene Symbol: LOC101418894
3 Cross references
201 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSDNOG00000042209
Gene Symbol: FSHR
2 Cross references
200 Possible Orthologues:

Free Fatty Acid Receptor 1

Ensembl ID : ENSDNOG00000041489
Gene Symbol: FFAR1
2 Cross references
76 Possible Orthologues:

Free Fatty Acid Receptor 2

Ensembl ID : ENSDNOG00000001937
Gene Symbol: FFAR2
4 Cross references
339 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSDNOG00000010080
Gene Symbol: FRK
4 Cross references
217 Possible Orthologues:

Galactosidase Alpha

Ensembl ID : ENSDNOG00000015959
Gene Symbol: GLA
2 Cross references
197 Possible Orthologues:

Galectin 1

Ensembl ID : ENSDNOG00000038381
Gene Symbol: LGALS1
4 Cross references
331 Possible Orthologues:

Galectin 3

Ensembl ID : ENSDNOG00000036172
Gene Symbol: LGALS3
4 Cross references
218 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha1

Ensembl ID : ENSDNOG00000044712
Gene Symbol: GABRA1
4 Cross references
201 Possible Orthologues:

Gamma-Aminobutyric Acid Type A Receptor Subunit Alpha2

Ensembl ID : ENSDNOG00000000669
Gene Symbol: GABRA2
2 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).